Cargando...
The CD40-CD40L Dyad as Immunotherapeutic Target in Cardiovascular Disease
Chronic inflammation drives the development of atherosclerosis. Despite optimal treatment of classical cardiovascular risk factors, a substantial portion of the population has elevated inflammatory biomarkers and develops atherosclerosis-related complications, indicating that a residual inflammatory...
Guardado en:
| Publicado en: | J Cardiovasc Transl Res |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Springer US
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7892683/ https://ncbi.nlm.nih.gov/pubmed/32222950 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12265-020-09994-3 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|